Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 9/20 | 0.56 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.51 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.51 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.51 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 2/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.41 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10590591 | 0.90 | ESR1 (0.59) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL29228901 | 0.90 | ESR1 (0.59) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL10592549 | 0.85 | ESR1 (0.50) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL11807929 | 0.85 | ESR1 (0.50) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL439370 | 0.85 | ESR1 (0.68) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL1264788 | 0.85 | ESR1 (0.68) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL5909518 | 0.85 | ESR1 (0.68) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL13509243 | 0.85 | ESR1 (0.68) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL539846 | 0.85 | ESR1 (0.68) | ESR1AKR1C4AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL76574 | 0.85 | LMNA (0.41) | NR5A2NR5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4722276-A1 | LOW MELTING CARBOXAMIDE HALS FOR IMPROVED STABILIZATION OF POLYAMIDES | CLARIANT INTERNATIONAL LTD (CH) | 2026-04-08 | — | — | EP | disclosed |
| EP-4722284-A1 | LOW MELTING CARBOXAMIDE HALS FOR IMPROVED STABILIZATION OF POLYMERS OR RESINS | CLARIANT INTERNATIONAL LTD (CH) | 2026-04-08 | — | — | EP | disclosed |
| US-20110054220-A1 | POLYETHER POLYOLS, POLYESTER POLYOLS AND POLYURETHANES OF LOW RESIDUAL ALDEHYDE CONTENT | GOH CHIN SIONG | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054220-A1 | POLYETHER POLYOLS, POLYESTER POLYOLS AND POLYURETHANES OF LOW RESIDUAL ALDEHYDE CONTENT | PUF60, GPX4, AOX1 | ESR1 1476/4885AKR1C4 20/4885AKR1C3 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.